Bipolar Disorder (2018) |
1.18 |
4 |
1 |
2.2 |
-0.63 |
3.7e-01 |
ADD3 C2orf15 GNL3 UBE2Q2P1 |
Bipolar Disorder or Schizophrenia |
1.20 |
9 |
6 |
13.3 |
-0.41 |
2.4e-01 |
AC103965.1 ACTR1A CHRNA5 CTCF FBXO38 GNL3 RP11-182J1.16 UBE2Q2P1 ZSCAN2 |
Depressed Affect (Nagel 2018) |
1.01 |
4 |
2 |
4.4 |
-0.37 |
6.3e-01 |
GMPPB PTCH1 RP1-18D14.7 RPS6KL1 |
Intelligence (Savage-Jansen 2018) |
1.15 |
19 |
10 |
22.2 |
0.22 |
3.1e-01 |
ACTR1A BTG3 CENPW CRAT FOXO3 GMPPB GNL3 HERC1 JUND LMOD1 NEGR1 PEF1 PPA2 PTCH1 RP11-165J3.6 RP11-435O5.5 SERPING1 SUOX TRIOBP |
Neuroticism (Nagel 2018) |
1.08 |
8 |
4 |
8.9 |
-0.17 |
6.1e-01 |
ADM BTG3 CENPW FBXO38 PTCH1 RPS6KL1 SBF2 SERPING1 |
Schizophrenia (2018) |
1.10 |
6 |
5 |
11.1 |
-0.95 |
1.2e-03 |
AC103965.1 ACTR1A CHRNA5 GNL3 RP11-182J1.16 UBE2Q2P1 |
Schizophrenia vs Biploar Disorder |
1.10 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
C2orf15 |
Worry (Nagel 2018) |
1.16 |
7 |
3 |
6.7 |
0.09 |
8.4e-01 |
ACTR1A ADK CENPW GNL3 PTCH1 RPS6KL1 VCL |
Alzheimer’s Disease (including proxy) |
0.94 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SPPL2A |
Crohns Disease (2017) |
1.48 |
15 |
12 |
26.7 |
0.63 |
2.1e-03 |
AC010883.5 ADCY3 CAMK2G FUT2 GSDMB IKZF3 ITPKC ORMDL3 PDLIM4 SH3D21 SLC22A5 SMAD3 STARD10 TSPAN14 UQCRQ |
Irritable Bowel Disease (IBD) |
1.59 |
15 |
11 |
24.4 |
0.69 |
7.3e-04 |
AC010883.5 ADCY3 AHSA2 BACH2 FUT2 GSDMB IKZF3 ITPKC ORMDL3 PDLIM4 SLC22A5 SMAD3 STARD10 TSPAN14 UQCRQ |
Ulcerative Colitis (UC) |
1.44 |
9 |
5 |
11.1 |
0.85 |
9.8e-04 |
AC026740.1 AHSA2 EIF6 GMPPB GSDMB IKZF3 ORMDL3 PDLIM4 RP3-395M20.9 |
Major Depression (MDD) |
1.33 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
NEGR1 |
Reaction Time |
1.11 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FOXO3 |
Verbal and Numeric Reasoning (VNR) |
1.21 |
9 |
6 |
13.3 |
0.30 |
3.4e-01 |
ALKBH5 BTG3 FOXO3 GMPPB GNL3 NEGR1 PEF1 PPA2 SUOX |
Breast Cancer |
1.17 |
9 |
6 |
13.3 |
-0.35 |
3.3e-01 |
ADCY3 ATE1 HSPA4 MKL1 MLLT10 PCM1 RPS23 SLC22A5 UQCRQ |
Ovarian Cancer |
1.00 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
DNALI1 HOXB2 |
Prostate Cancer |
1.21 |
4 |
1 |
2.2 |
0.71 |
1.8e-01 |
EEFSEC NUCKS1 PPA2 RIF1 |
Age at First Birth |
1.01 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
GMPPB |
Bipolar Disorder (2011) |
1.59 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
GNL3 |
Body Mass Index (BMI) (2010) |
1.20 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
ADCY3 NEGR1 |
Coronary Artery Disease (CAD) |
1.45 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CELSR2 |
Crohns Disease (2012) |
1.26 |
8 |
8 |
17.8 |
0.52 |
1.0e-01 |
FUT2 GSDMB IKZF3 ORMDL3 PDLIM4 SLC22A5 SMAD3 UQCRQ |
HDL Cholesterol |
1.48 |
7 |
5 |
11.1 |
0.41 |
3.1e-01 |
C6orf106 CTCF GSDMB IKZF3 ORMDL3 PABPC4 RPAP1 |
LDL Cholesterol |
1.61 |
5 |
4 |
8.9 |
0.22 |
6.4e-01 |
C6orf106 CELSR2 EVI5 FUT2 RP11-680F20.12 |
Lupus |
1.29 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
APIP TCP11 ZNF76 |
Neuroticism (2016) |
1.20 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
ADM SBF2 |
Primary Biliary Cirrhosis |
1.35 |
4 |
4 |
8.9 |
0.73 |
9.7e-02 |
GSDMB IKZF3 IL7R ORMDL3 |
Schizophrenia (2014) |
0.99 |
6 |
5 |
11.1 |
-0.46 |
3.0e-01 |
AC103965.1 ACTR1A GNL3 RP11-182J1.16 SMG6 UBE2Q2P1 |
Triglycerides |
1.11 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
NRBF2 PCSK7 |
Type 2 Diabetes (T2D) (2012) |
1.50 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
IGF2BP2 STARD10 |
Ulcerative Colitis |
1.50 |
4 |
4 |
8.9 |
0.72 |
1.0e-01 |
GSDMB IKZF3 ORMDL3 RP3-395M20.9 |
Blood Eosinophil Count |
1.80 |
58 |
43 |
95.6 |
-0.41 |
4.0e-04 |
AC010883.5 AC103965.1 ADD3 AHSA2 ARMC2 BACH2 C16orf93 C20orf112 CCDC9 COG6 CTA-293F17.1 CTD-2007H13.3 DEF6 DMPK DMWD EXOC2 FBXO38 FCHO2 FOXO1 GNA12 HAUS4 HMOX2 HSPA4 IL1RL1 IL7R IQCH ITPKC LINC00674 LRP1 MSL1 PCBP2 PDLIM4 PSTPIP1 RBBP8 RP11-182J1.16 RP11-298I3.1 RP11-425D10.10 RP11-680F20.12 RP3-395M20.9 SCAPER SEC24C SLC22A5 SMAD3 SMPD2 SUOX SYMPK TBX6 TCP11 TEPP THRA TOM1L2 TPRA1 TSPY26P UQCRQ ZNF652 ZNF76 ZSCAN2 ZUFSP |
Blood Platelet Count |
1.26 |
94 |
72 |
160.0 |
-0.19 |
5.4e-02 |
AC010883.5 AC103965.1 ADD3 ADK AP4M1 ATG16L2 ATP2A3 BCAR1 BIN3 C10orf11 C16orf93 C1orf54 C20orf203 C6orf106 C9orf156 CAPZB CCDC66 CEPT1 CFDP1 CNPY4 CNTN2 DENND2D DEPDC6 DMPK DMWD EEFSEC EVI5 FAM69A FCGR2B FCHO2 FGD6 FOXO1 FUT2 GIPC2 GNA12 GNL3 HELLS HHIP-AS1 HMGN1 HMOX2 IGF2BP2 IMMT JHDM1D LHFPL2 LSMD1 MARCH7 MUTYH NIPSNAP1 NRBF2 OR2AE1 OTUD4 PCSK7 PDE8B PDLIM4 PGD PIF1 PLAC9 PPA2 RAI14 RALY RARB RP11-157P1.5 RP11-165J3.6 RP11-182J1.16 RP11-425D10.10 RP11-673E1.1 RP11-797A18.4 RP11-800A3.7 RP1-18D14.7 RP11-95P2.1 RPS6KL1 SERPING1 SERTAD2 SH3D21 SLC22A5 SMG6 SMPD2 SNX33 SSH2 SYMPK TIGD2 TMEM170A TMEM180 TMEM185B TOP2B TPM1 TRIM4 TRIT1 UQCRQ VCL WNT2B ZMAT5 ZNF260 ZSCAN2 |
Blood Red Count |
1.01 |
75 |
54 |
120.0 |
0.03 |
7.6e-01 |
ACSS2 ADM ALKBH5 AP4M1 ARMC2 ATP13A2 ATPAF1 BACH2 C16orf93 C20orf203 C9orf156 CENPW CNPY4 CNTN2 CROCC CTCF CTD-2514C3.1 CTD-2524L6.3 DCBLD1 DYNC1LI2 EIF2AK4 EPHA2 FAM69A FCGR2B FOXO1 GJA1 GNL3 GPATCH2L GPRIN3 HELLS HOXB2 HOXB-AS1 IGF2BP2 LIN52 LINC00649 LSMD1 MAP1LC3A MAPKBP1 MRC2 MST1L MUTYH ORMDL3 PABPC4 PRIM2 PRR15L PSTPIP1 RAI14 RP11-425D10.10 RP11-435O5.5 RP11-673E1.1 RP11-797A18.4 RP1-18D14.7 RPAP1 RSL24D1P6 SBF2 SERPING1 SERTAD2 SHKBP1 SMG6 SMPD2 SNX33 SSH2 STRA13 SUOX SYMPK TBX6 TMEM165 TMEM9B TRIOBP TRMT61B TSPAN3 UBE2Q2 UBE2Q2P1 ULK4 WDR91 |
Blood White Count |
2.45 |
72 |
50 |
111.1 |
-0.19 |
7.8e-02 |
ACTR1A ADAM33 AHSA2 ALKBH5 ARHGAP42 ASCC2 BACH2 C16orf93 C1orf54 CCDC9 CDK5RAP3 CENPW CEPT1 DEF6 EVI5 FAM213A FAM69A FBXO38 FCGR2B GM2A GMPPB GNA12 GSDMB HELLS HMOX2 HOXC8 IFITM3 IKZF3 IL1RL1 ITCH ITGA2 ITPKC KB-1107E3.1 KLF6 MAP1LC3A MARCH7 MSL1 NF2 NFE2L1 NIPSNAP1 NRBF2 ORMDL3 PDLIM4 PEAK1 PPA2 PRR15L PSTPIP1 PTCH1 RAI14 RALY RIOK1 RP11-435O5.5 RP11-797A18.4 RPL10A SCAPER SLC22A5 SMG6 SMPD2 SNRPF SPINK9 SPPL2A SSH2 TBX6 THRA TIGD2 TOM1L2 TSPAN14 TSPAN3 UQCRQ ZMAT5 ZNF652 ZNF76 |
Heel T-Score |
1.94 |
77 |
57 |
126.7 |
0.13 |
2.0e-01 |
AC010883.5 AC103965.1 ACSS2 ASCC2 ATE1 BMP4 C11orf46 C16orf93 C2orf15 CAMK2G CAPZB CDK5RAP3 CTC-228N24.3 DDX5 DEF6 DGKQ DYNC1LI2 EIF3E EP300 EVI5 FAM213A FAM3C FCHO2 GAB2 GJA1 GNA12 GRK5 HHIP-AS1 HSPA4 HSPG2 IGF2BP2 IQCH ITCH ITPR1-AS1 LACTB2 LSMD1 LTBP3 MAP1LC3A MKL1 MRC2 NEGR1 NFE2L1 NIPSNAP1 OTUD4 PCGF2 PEAK1 PIP4K2B PLAC9 PRR15L PTCH1 PTPRM RALY RP11-165J3.6 RP11-435O5.5 RP11-95P2.1 RPL10A SERPING1 SERTAD2 SMG6 SPPL2A SSH2 SSR3 STRA13 TCP11 THAP3 THSD4 TMEM9B TRIOBP TRMT61B TSPAN14 TSPAN3 UBE2Q2P1 USP3 VGLL4 WNT2B ZNF438 ZNF76 |
BMI |
1.29 |
56 |
37 |
82.2 |
0.45 |
3.1e-04 |
ACTR1A ADCY3 ARHGEF26 ATP13A2 C16orf93 C6orf106 CCDC171 CDK5RAP3 CEP41 CTD-2524L6.3 EP300 EVI5 FAM69A FGFR1 FOXO3 GAB2 GIPC2 GMPPB GNL3 GTF2IRD2 HOXB-AS1 IQCH ITCH KB-1107E3.1 KLF16 KLHL24 LINC00674 LMOD1 LOXL1-AS1 LRP1 MKL1 MLLT10 MTA3 MUTYH NEGR1 NFE2L1 NRBF2 OTUD4 PABPC4 PEF1 PSTPIP1 PTPRM RAB4B RALY RP11-797A18.4 RP1-18D14.7 RP3-395M20.9 SMG6 SNX11 SSH2 SUOX TBX6 THAP3 TRMT61B TSPAN4 UBE2R2 |
Height |
2.41 |
169 |
144 |
320.0 |
0.02 |
8.2e-01 |
AC010883.5 AC103965.1 ACSS2 ADAMTS5 ADCY3 ADM AFAP1 AFAP1-AS1 ALKBH5 ARHGEF26 ARHGEF38 ARMC2 ASAH1 ASB13 ATP13A2 BCAR1 BMF BTBD8 C10orf11 C11orf46 C1orf54 C20orf24 C6orf106 C9orf156 CCDC144B CCDC66 CCDC9 CELSR2 CENPW CFDP1 COG6 CRIM1 CROCC CTA-293F17.1 CTCF CTD-2524L6.3 CWC25 DDX5 DEF6 DEPDC6 DMWD DRAM1 DYNC1LI2 EFEMP1 EIF2AK4 EIF6 ERC1 EVI5 EXOC2 FAM69A FOXO3 FRK FUT2 FZR1 GAB2 GBA GIPC2 GNA12 GNL3 GNPTAB GOLGA6L4 GRK5 GTF2IRD2 HHIP-AS1 HMGN1 HOXB2 HOXB-AS1 HSPG2 IKZF3 ISCA1 ITCH ITPKC KIAA0753 KLHL24 LINC00674 LLGL2 LOX LOXL1-AS1 LRP1 LRRC37B LSM3 LTBP3 LYSMD4 MAP1LC3A MET MFAP2 MRC2 MRPS6 MSL1 MST1L MTMR11 MUTYH NCBP1 NFE2L1 NUCKS1 NUDT2 NUDT5 ORMDL3 OTUD4 PABPC4 PADI2 PDE2A PDHX PDLIM4 PEAK1 PEF1 PGD PIP4K2B PLA2G4B PLEKHA1 PLEKHM1P PPA2 PROCR PRR15L PSTPIP1 PTCH1 PTPRM RALY RBBP8 RP11-108M9.4 RP11-108M9.5 RP11-157P1.5 RP11-165J3.6 RP11-182J1.14 RP11-182J1.16 RP11-382A20.2 RP11-425D10.10 RP11-435O5.5 RP11-797A18.4 RP11-95P2.1 RPL10A RPS6KL1 RRP15 SBF2 SCAPER SEC61A2 SGMS1 SH3D21 SHKBP1 SLC22A5 SLC2A9 SMPD2 SMURF2 SNX11 SPPL2A SSH2 ST3GAL4 STRA13 TBX6 TCP11 TCTN2 TGFB2 TMEM165 TMEM170A TMEM180 TMEM185B TMUB1 TRIB1 TRIOBP TSPAN3 UBE2Q2 UBE2Q2P1 UBE2R2 UQCRQ ZMAT5 ZNF438 ZNF652 ZNF76 ZSCAN2 |
Waist Hip Ratio (WHR) |
1.49 |
49 |
30 |
66.7 |
0.22 |
1.1e-01 |
ABTB1 AC103965.1 ADM ALKBH5 AMPD3 ARHGEF26 ATP13A2 C10orf11 CCDC144B CENPW CEP41 CFH COL15A1 CTC-228N24.3 CTCF DGKQ DMWD EML3 FOXO3 FUT2 GNL3 HERC1 HHIP-AS1 HMOX2 HOXC8 HSPA4 IGF2BP2 IQCH JUND LYSMD4 MAPKBP1 MFAP2 MST1L NID2 OTUD4 PIP4K2B PLA2G4B RP11-182J1.14 RP11-182J1.16 RP11-95P2.1 RPAP1 RPL10A SBF2 TCTN2 TOM1L2 TSPAN4 U2SURP UBE2Q2P1 VGLL4 |
Systolic Blood Pressure |
1.70 |
64 |
42 |
93.3 |
-0.38 |
4.8e-04 |
ACTR1A ADCY3 ADK ADM AFAP1 AFAP1-AS1 ARHGAP42 ARHGEF26 ATP2B1 BCAR1 BMP4 CAMK1D CDC123 CFDP1 CTC-228N24.3 CTD-2514C3.1 DCBLD1 DDX5 DEF6 DMPK DMWD EIF2AK4 ELMSAN1 EPHA2 FAM149B1 FAM213A FBXO38 FUT2 GIPC2 HAUS4 HELLS HHIPL1 HOXC8 HSPA4 KB-1107E3.1 KIAA0753 MAPKBP1 MET MRC2 NRBF2 PLA2G4B RP11-298I3.1 RP11-800A3.7 RPL10A RPS6KL1 SBF2 SEC24C SERPING1 SH3TC2 SLC24A3 SMAD3 SNX11 SPINK9 TCP11 THAP3 TMEM170A TRIOBP TSHZ3 TSPAN14 TTC18 ULK4 VCL VGLL4 ZNF652 |
Smoking Status |
1.31 |
8 |
2 |
4.4 |
-0.16 |
7.1e-01 |
ACTR1A GMPPB IQCH MET RARB SUOX ZFHX3 ZNF652 |
Allergy or Eczema |
1.99 |
24 |
14 |
31.1 |
-0.49 |
7.6e-03 |
AC010883.5 AMPD3 BACH2 BCAR1 C6orf106 EVI5 FAM69A FOXO1 GRK5 GSDMB IKZF3 IL1RL1 IL7R IQCH MSL1 NEGR1 ORMDL3 SMAD3 SUOX THRA TMEM170A TOM1L2 UQCRQ ZNF652 |
Cardiovascular Disease |
1.48 |
26 |
14 |
31.1 |
-0.07 |
7.0e-01 |
ADK ARHGAP42 ATP2B1 BCAR1 C1GALT1 CACNA1D CELSR2 CEP41 CFDP1 FUT2 HOXC8 HSPA4 KB-1107E3.1 KLF16 LMOD1 MET NEGR1 NPNT NRBF2 RPAP1 SSH2 SUOX THAP3 TMEM170A TSPAN3 ZNF652 |
Hypothyroidism (self reported) |
1.26 |
10 |
7 |
15.6 |
-0.36 |
3.1e-01 |
BACH2 C9orf156 CTCF FUT2 IL7R JUND NCBP1 PLEKHA1 SUOX XPA |
Respiratory disease |
3.42 |
30 |
22 |
48.9 |
-0.68 |
6.0e-07 |
ADAM19 BACH2 C16orf93 C1orf54 DDX5 DEF6 DMWD EEFSEC FOXO1 GSDMB HOXB2 IKZF3 IL1RL1 IL7R IQCH LRP1 LTBP3 MSL1 ORMDL3 PDLIM4 RP11-425D10.10 SLC22A5 SMAD3 SUOX TCP11 THRA TSPAN14 UQCRQ ZNF652 ZNF76 |
Type 2 Diabetes (T2D) (2018) |
1.69 |
11 |
7 |
15.6 |
-0.71 |
1.0e-02 |
AC010883.5 C1GALT1 CAMK1D CDC123 CENPW CFDP1 CLPB IGF2BP2 LOC100133893 PLA2G4B STARD10 |
Lung FVC |
2.10 |
84 |
63 |
140.0 |
-0.18 |
6.5e-02 |
AFAP1L1 ARAP1-AS1 ATP13A2 ATP6V0D1 BIN3 BMF BMP4 C10orf11 C6orf106 CAMK1D CAMK2G CCDC171 CDC123 CDK5RAP3 CENPW CFH CHRNA5 CROCC CTC-228N24.3 CTD-2514C3.1 DSP EFEMP1 EIF2AK4 EIF6 EML3 EPHA2 EPHX4 ERC1 FBXO38 FOXO3 GM2A GMPPB HMOX2 HOXC8 HSPA4 IGF2BP2 INTS12 IQCH ITCH JUND KCNQ5 LLGL2 LONRF2 LOX LOXL1-AS1 MAP1LC3A MFAP2 MICAL3 MRPS6 MST1L NFE2L1 NUCKS1 NUDT5 PAIP1 PCSK7 PLEKHM1P PROCR PTCH1 RALY RBBP8 RP11-108M9.5 RP11-382A20.2 RP11-435O5.5 RPL10A RRP15 SEC24C SHKBP1 SLC22A5 SLMAP SMPD2 SMURF2 SOGA2 SPTBN5 STARD10 STRA13 SUOX TCP11 THSD4 TIGD2 TMUB1 TRIOBP ZFHX3 ZMAT5 ZNF76 |
Neuroticism |
1.11 |
10 |
2 |
4.4 |
-0.04 |
9.0e-01 |
ADM BTG3 CENPW FBXO38 GAB2 IQCH PTCH1 RPS6KL1 SBF2 SERPING1 |
Chronotype (morning person) |
1.08 |
5 |
1 |
2.2 |
0.05 |
9.4e-01 |
C1orf54 CTD-2524L6.3 EVI5 SHB TMEM180 |
Hair Pigment |
0.51 |
42 |
31 |
68.9 |
-0.21 |
1.3e-01 |
AC010883.5 ACSS2 ADAMTS5 ADCY3 ADD3 ADM ARHGAP42 ATP2B1 C20orf112 C20orf24 C6orf106 C9orf156 CNTN2 DEF6 EIF3E EIF6 EMB EML4 EXOC2 FOXO3 FRAS1 GAB2 GBA HMOX2 HOXB-AS1 ITCH LRRN2 MAP1LC3A MSL1 NFE2L1 NUCKS1 PPP1R3B PROCR PRR15L RALY RP5-1085F17.3 RSL24D1P6 SBF2 SH3D21 SNX11 SUOX ZNF76 |
Tanning |
0.77 |
20 |
15 |
33.3 |
0.48 |
1.7e-02 |
ACSS2 ADCY3 C20orf24 CNTN2 CTD-2514C3.1 DTWD1 EIF6 GAB2 GBA GNL3 HMOX2 ITCH MAP1LC3A NRBF2 PROCR RALY RP11-305K5.1 RP5-1085F17.3 SNX11 SSR3 |
Hand grip strength (left) |
1.57 |
24 |
12 |
26.7 |
0.49 |
4.3e-03 |
ACSS2 ACTR1A ADCY3 AFAP1 AFAP1-AS1 DEF6 EIF6 GBA HOXB2 ITCH LOXL1-AS1 MAP1LC3A NUCKS1 PDLIM4 PEF1 PIP4K2B PROCR RPS6KL1 SLC22A5 SNX11 TCP11 TGFB2 TRIOBP ZNF76 |
Number of treatments/medications taken |
1.32 |
6 |
2 |
4.4 |
-0.60 |
2.1e-01 |
GMPPB LINC00674 LRP1 RNF38 RPS6KL1 ZNF652 |
Sensitivity / hurt feelings |
1.11 |
2 |
1 |
2.2 |
-0.94 |
6.5e-02 |
PPP1R3B PTCH1 |
Frequency of depressed mood in last 2 weeks |
1.13 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SERPING1 |
Hearing difficulty/problems: Yes |
1.17 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ADK |
Relative age of first facial hair |
1.12 |
4 |
1 |
2.2 |
-0.97 |
5.0e-03 |
AC004041.2 FOXO3 HSPA4 VGLL4 |
Ever had hysterectomy (womb removed) |
1.01 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
C11orf46 |
Systolic blood pressure, automated reading |
1.73 |
28 |
15 |
33.3 |
-0.55 |
7.7e-04 |
ADK ARHGAP42 ATP2B1 BCAR1 CAMK1D CFDP1 DEF6 DMPK DMWD EIF2AK4 FBXO38 HAUS4 HHIPL1 HOXC8 NFE2L1 NRBF2 PPA2 PPP1R3B RP11-298I3.1 SBF2 SEC24C SNX11 SPINK9 TCP11 THAP3 TMEM170A ULK4 VGLL4 |
Eye problems/disorders: Diabetes related eye disease |
1.11 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
IGF2BP2 |
Angina |
1.26 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
CELSR2 ZNF652 |
Vitamin and mineral supplements |
1.29 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
LRP1 |
Medication: Metformin |
1.62 |
4 |
2 |
4.4 |
-0.85 |
1.5e-01 |
AC010883.5 CAMK1D CDC123 IGF2BP2 |
Diabetes (father) |
1.18 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
AC010883.5 IGF2BP2 |
Diabetes (mother) |
1.61 |
4 |
4 |
8.9 |
-0.93 |
7.1e-02 |
CAMK1D CDC123 IGF2BP2 STARD10 |
Pack years adult smoking proportion |
1.53 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
CHRNA5 RAB4B |
Impedance of leg (right) |
1.67 |
64 |
46 |
102.2 |
0.02 |
8.5e-01 |
AC010883.5 AC103965.1 ACTR1A ADCY3 ADM ALKBH5 AMPD3 ARVCF ATP13A2 BCAR1 BTBD8 C10orf11 C16orf93 C6orf106 CAMK2G CFDP1 CROCC CTC-228N24.3 EP300 EPHA2 EVI5 GMPPB GNL3 GOLGA6L4 GTF2IRD2 HELLS HOXC8 ITCH JUND KLF16 LMOD1 LOC400043 LSM3 MFAP2 MKL1 MST1L MTMR11 NEGR1 NUCKS1 OTUD4 PABPC4 PEAK1 PLA2G4B PSTPIP1 PTCH1 RALY RP11-108M9.5 RP11-165J3.6 RP11-182J1.14 RP11-182J1.16 RP11-382A20.2 RP11-797A18.4 SBF2 SCAPER SCARF2 SH3D21 SMG6 SUOX TBX6 TSPAN3 TSPAN4 UBE2Q2P1 ZNF652 ZSCAN2 |
Leg fat-free mass (left) |
1.72 |
57 |
43 |
95.6 |
0.36 |
1.1e-03 |
ACSS2 ACTR1A ADM ARHGEF26 BTBD8 C10orf11 C16orf93 C1orf54 C20orf24 C6orf106 CENPW CTC-228N24.3 DEF6 EIF6 EPHA2 FOXO3 FZR1 GIPC2 GMPPB GNA12 HHIP-AS1 ITCH KLF16 KLHL24 LMOD1 LOXL1-AS1 MAP1LC3A MKL1 MSL1 NEGR1 NUCKS1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PPA2 PROCR PTCH1 RALY RP11-435O5.5 RPL10A SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SNX11 SUOX TBX6 TCP11 TGFB2 TSPAN4 UQCRQ ZMAT5 ZNF76 |
Trunk fat percentage |
1.26 |
34 |
22 |
48.9 |
0.30 |
7.2e-02 |
AC103965.1 ADCY3 ADM C16orf93 C6orf106 CCDC171 CENPW EML3 FOXO3 GBA GNA12 GOLGA6L4 HOXC8 IQCH JUND KCNG3 KLHL24 LINC00674 LMOD1 NEGR1 NTM OTUD4 PABPC4 RARB RP11-182J1.14 RP11-182J1.16 RP11-95P2.1 RPS6KL1 SBF2 SNX11 SYNM THAP3 UBE2Q2P1 ZSCAN2 |
Hand grip strength (right) |
1.64 |
18 |
13 |
28.9 |
0.62 |
4.9e-04 |
ACSS2 ACTR1A ADCY3 AFAP1 ATP2A3 EIF6 HOXB2 ITCH LOXL1-AS1 MAP1LC3A NUCKS1 PDLIM4 PEF1 PIP4K2B PROCR SLC22A5 TCP11 TGFB2 |
Current tobacco smoking |
1.19 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ACTR1A |
Maternal smoking around birth |
1.15 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ACTR1A TSPAN14 |
Fed-up feelings |
1.09 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
GMPPB PPP1R3B RPS6KL1 |
Relative age voice broke |
0.97 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
FOXO3 RP11-95P2.1 |
Taking other prescription medications |
1.34 |
8 |
3 |
6.7 |
-0.87 |
5.1e-03 |
ADAM19 GMPPB GSDMB IKZF3 IL1RL1 ORMDL3 RPS6KL1 ZNF652 |
Age when periods started (menarche) |
1.26 |
14 |
9 |
20.0 |
-0.12 |
6.8e-01 |
ADCY3 AP4M1 CENPW COG6 FOXO3 GAB2 GMPPB GNL3 HMGN1 KLF16 NEGR1 NUCKS1 PAN3-AS1 SUOX |
Bilateral oophorectomy (both ovaries removed) |
1.00 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
C11orf46 |
Heel bone mineral density (BMD) T-score, automated (left) |
1.46 |
18 |
9 |
20.0 |
-0.19 |
4.2e-01 |
BMP4 DGKQ DYNC1LI2 EP300 FAM213A FAM3C HHIP-AS1 LACTB2 MRC2 OTUD4 PPP1R3B PTCH1 RP11-165J3.6 RP11-435O5.5 SERTAD2 SMG6 THAP3 WNT2B |
High blood pressure |
1.49 |
17 |
9 |
20.0 |
-0.38 |
1.0e-01 |
ARHGAP42 ATP2B1 C1GALT1 CEP41 CFDP1 EEFSEC FUT2 HOXC8 KB-1107E3.1 MET NEGR1 NRBF2 PDLIM4 SLC22A5 SUOX TSPAN3 ZNF652 |
Hayfever, allergic rhinitis or eczema |
1.91 |
15 |
13 |
28.9 |
-0.84 |
8.2e-06 |
BACH2 C6orf106 FOXO1 GSDMB IKZF3 IL1RL1 IL7R MSL1 ORMDL3 SMAD3 SUOX THRA TOM1L2 UQCRQ ZNF652 |
Multivitamins +/- minerals |
1.35 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
NUCKS1 PGD |
Supplements: Glucosamine |
1.26 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
NRBF2 |
Medication: Atenolol |
1.20 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MET |
Medication: Levothyroxine sodium |
1.24 |
4 |
4 |
8.9 |
-0.47 |
5.3e-01 |
BACH2 C9orf156 NCBP1 SUOX |
Sitting height |
2.22 |
84 |
56 |
124.4 |
0.12 |
1.9e-01 |
AC103965.1 ACSS2 ADCY3 ADM AFAP1 AFAP1-AS1 ATP13A2 BEND3P3 BTBD8 C10orf11 C20orf24 C6orf106 C9orf156 CCDC171 CDON CENPW COX7A2L CRIM1 DEPDC6 DMWD DRAM1 DYNC1LI2 EFEMP1 EIF2AK4 EIF6 EML4 ERC1 EVI5 FAM69A FOXO3 FRK FUT2 FZR1 GNA12 GNPTAB GOLGA6L4 HELLS HERC1 HHIP-AS1 HOXB-AS1 HSPG2 ISCA1 ITCH LOXL1-AS1 LRP1 LRRC37B MAP1LC3A MFAP2 MRC2 MST1L MTA3 MTMR11 MUTYH NUCKS1 OTUD4 PDLIM4 PIP4K2B PLEKHA1 PPA2 PPP1R3B PROCR PTCH1 RALY RP11-182J1.14 RP11-182J1.16 RP11-425D10.10 RP11-435O5.5 RP11-95P2.1 RPL10A RRP15 SBF2 SLC22A5 SMPD2 ST3GAL4 STRA13 TGFB2 TMEM165 TRIOBP UBE2Q2P1 UQCRQ VGLL4 ZNF652 ZNF76 ZSCAN2 |
Chronic bronchitis/emphysema (father) |
1.50 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CHRNA5 |
High blood pressure (mother) |
1.34 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
HOXC8 TMEM170A |
Body mass index (BMI) |
1.19 |
32 |
17 |
37.8 |
0.41 |
1.5e-02 |
ACTR1A ADCY3 ATP13A2 C16orf93 C6orf106 CCDC171 CDK5RAP3 EP300 EVI5 FOXO3 GMPPB GNL3 ITCH KLF16 LINC00674 LMOD1 MKL1 MUTYH NEGR1 NFE2L1 OTUD4 PABPC4 PPP1R3B PTPRM RP11-797A18.4 RP1-18D14.7 RP3-395M20.9 SCAPER SMG6 SUOX TBX6 TSPAN4 |
Impedance of leg (left) |
1.66 |
66 |
45 |
100.0 |
-0.01 |
9.0e-01 |
AC010883.5 AC103965.1 ACTR1A ADCY3 ADM ALKBH5 AMPD3 ARVCF ATP13A2 BCAR1 BTBD8 C10orf11 C16orf93 C6orf106 CAMK2G CEP41 CFDP1 CROCC CTC-228N24.3 EP300 EPHA2 EVI5 GMPPB GNL3 GOLGA6L4 GTF2IRD2 HELLS ITCH JUND KLF16 LMOD1 LSM3 MFAP2 MKL1 MST1L MTMR11 NEGR1 NUCKS1 OTUD4 PABPC4 PEAK1 PPA2 PSTPIP1 PTCH1 RALY RP11-108M9.5 RP11-165J3.6 RP11-182J1.14 RP11-182J1.16 RP11-382A20.2 RP11-797A18.4 RPS6KL1 SBF2 SCAPER SCARF2 SH3D21 SMG6 SMPD2 SUOX TBX6 TSPAN3 TSPAN4 UBE2Q2P1 ULK4 ZNF652 ZSCAN2 |
Leg predicted mass (left) |
1.72 |
56 |
43 |
95.6 |
0.37 |
7.9e-04 |
ACSS2 ACTR1A ADM ARHGEF26 BTBD8 C10orf11 C16orf93 C1orf54 C20orf24 C6orf106 CENPW CTC-228N24.3 DEF6 EIF6 EPHA2 FOXO3 FZR1 GIPC2 GMPPB GNA12 HHIP-AS1 ITCH KLF16 KLHL24 LMOD1 LOXL1-AS1 MAP1LC3A MSL1 NEGR1 NUCKS1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PPA2 PROCR PTCH1 RALY RP11-435O5.5 RPL10A SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SNX11 SUOX TBX6 TCP11 TGFB2 TSPAN4 UQCRQ ZMAT5 ZNF76 |
Trunk fat mass |
1.30 |
33 |
24 |
53.3 |
0.41 |
1.3e-02 |
AC103965.1 ADCY3 ARHGEF26 C16orf93 C6orf106 CCDC171 FOXO3 GNA12 GOLGA6L4 IQCH ITCH JUND KB-1107E3.1 KLF16 KLHL24 LINC00674 LMOD1 MAP1LC3A NEGR1 OTUD4 PABPC4 PLEKHA1 RARB RP11-182J1.14 RP11-182J1.16 RP1-18D14.7 RP11-95P2.1 RPL10A SNX11 TBX6 THAP3 UBE2Q2P1 ZSCAN2 |
Waist circumference |
1.28 |
25 |
17 |
37.8 |
0.20 |
3.4e-01 |
ADCY3 C16orf93 C6orf106 CCDC171 FOXO3 GOLGA6L4 HOXC8 IQCH JUND KB-1107E3.1 KLF16 LINC00674 LMOD1 MICU3 MLLT10 NEGR1 OTUD4 PABPC4 RP11-182J1.16 RP3-395M20.9 RPL10A SMG6 SNX11 SUOX TBX6 |
Number of incorrect matches in round |
1.14 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TSPAN14 |
Past tobacco smoking |
1.29 |
3 |
3 |
6.7 |
0.00 |
1.0e+00 |
ACTR1A IQCH TMEM180 |
Alcohol usually taken with meals |
1.16 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ACTR1A SERPING1 |
Nervous feelings |
1.13 |
7 |
3 |
6.7 |
-0.09 |
8.3e-01 |
ACTR1A CENPW FBXO38 GNL3 PPP1R3B RPS6KL1 SBF2 |
Frequency of tenseness / restlessness in last 2 weeks |
0.94 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
GMPPB |
Hearing difficulty/problems with background noise |
1.12 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
NUCKS1 VGLL4 |
Hair/balding pattern: Pattern 2 |
1.13 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
C10orf11 |
Had other major operations |
1.07 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PPA2 |
Forced vital capacity (FVC) |
2.39 |
61 |
41 |
91.1 |
-0.07 |
5.2e-01 |
ADCY3 ATP13A2 BMF C10orf11 C11orf46 CAMK1D CCDC171 CDC123 CDK5RAP3 CENPW CHRNA5 CRIM1 CROCC CTC-228N24.3 CTCF DEF6 EFEMP1 EIF2AK4 EML3 ERC1 GNA12 GNPTAB HHIP-AS1 INTS12 IQCH LONRF2 LOXL1-AS1 MFAP2 MST1L NFE2L1 NUDT5 OTUD4 PADI2 PCSK7 PIP4K2B PLEKHA1 PLEKHM1P PPA2 PSTPIP1 PTCH1 RP11-108M9.4 RP11-108M9.5 RP11-182J1.14 RP11-182J1.16 RP11-382A20.2 RP11-435O5.5 RP11-797A18.4 RPL10A RRP15 SCAPER SEC24C SH3D21 SHKBP1 SLMAP SMPD2 SMURF2 SSH2 TCP11 TGFB2 UBE2Q2P1 ZNF76 |
Heel bone mineral density (BMD) T-score, automated (right) |
1.52 |
14 |
7 |
15.6 |
-0.11 |
7.0e-01 |
BMP4 EPHA2 FAM213A FAM3C HHIP-AS1 OTUD4 PPP1R3B PTCH1 RP11-165J3.6 SERTAD2 SMG6 SNCAIP THAP3 WNT2B |
Ever unenthusiastic/disinterested for a whole week |
0.87 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
GMPPB |
Qualifications: None of the above |
1.21 |
6 |
4 |
8.9 |
-0.21 |
6.1e-01 |
ACTR1A FOXO3 GMPPB NEGR1 PPA2 SUOX |
Mouth/teeth dental problems |
1.05 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
FUT2 |
Heart attack |
1.14 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
CELSR2 ZNF652 |
Allergy |
2.49 |
25 |
17 |
37.8 |
0.82 |
1.0e-08 |
BACH2 C6orf106 CAMK2G DEF6 EEFSEC FOXO1 GSDMB IKZF3 IL1RL1 IL7R IQCH LRP1 MSL1 NUDT13 ORMDL3 PDLIM4 RBBP8 RP5-1085F17.3 SEC24C SLC22A5 SMAD3 SUOX THRA UQCRQ ZNF652 |
Diabetes (self-reported) |
1.57 |
4 |
1 |
2.2 |
-0.91 |
3.4e-02 |
AC010883.5 FBXO38 IGF2BP2 LOC100133893 |
Hayfever/allergic rhinitis (self-reported) |
1.64 |
7 |
2 |
4.4 |
-0.95 |
9.9e-04 |
BACH2 GSDMB IKZF3 IL1RL1 IL7R SMAD3 SUOX |
Medication: Simvastatin |
1.31 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
CELSR2 DMWD FUT2 |
Fluid intelligence score |
1.20 |
9 |
4 |
8.9 |
0.36 |
2.3e-01 |
ALKBH5 BTG3 FOXO3 GMPPB NEGR1 PEF1 PPA2 PTCH1 RARB |
Illnesses of siblings |
1.35 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SSH2 |
Neuroticism score |
1.19 |
7 |
3 |
6.7 |
0.04 |
9.2e-01 |
ADM FBXO38 PPP1R3B PTCH1 RPS6KL1 SBF2 SERPING1 |
Weight |
1.47 |
55 |
39 |
86.7 |
0.53 |
2.0e-06 |
AC103965.1 ACSS2 ACTR1A ADCY3 ARHGEF26 C16orf93 C6orf106 CCDC171 CENPW EIF6 FOXO1 FOXO3 FZR1 GIPC2 GMPPB GNA12 GOLGA6L4 HHIP-AS1 ITCH KB-1107E3.1 KLF16 KLHL24 LINC00674 LMOD1 MAP1LC3A NEGR1 NUCKS1 OTUD4 PABPC4 PEF1 PLEKHA1 PPA2 PROCR RALY RP11-182J1.14 RP11-182J1.16 RP11-435O5.5 RP1-18D14.7 RP11-95P2.1 RP3-395M20.9 RPL10A SLC22A5 SMG6 SMPD2 SNX11 SUOX TBX6 TCP11 TGFB2 TRMT61B TSPAN4 UBE2Q2P1 ZMAT5 ZNF76 ZSCAN2 |
Impedance of arm (right) |
1.57 |
55 |
41 |
91.1 |
-0.22 |
9.0e-02 |
AC103965.1 ACTR1A ADM AMPD3 ARVCF ATP13A2 C10orf11 C6orf106 CENPW EFEMP1 EML3 EP300 EVI5 FOXO3 GAB2 GBA GMPPB GNL3 GOLGA6L4 GTF2IRD2 HOXC8 ITCH JUND LMOD1 LOC400043 LOXL1-AS1 MFAP2 MKL1 MST1L MTMR11 NEGR1 NFE2L1 NRBF2 NUCKS1 PEF1 PPP1R3B PSTPIP1 RALY RIF1 RP11-108M9.4 RP11-108M9.5 RP11-182J1.14 RP11-182J1.16 RP11-797A18.4 RP3-395M20.9 SBF2 SCARF2 SMAD3 SMG6 SUOX TBX6 TSPAN3 TSPAN4 UBE2Q2P1 ZNF652 |
Arm fat percentage (right) |
1.18 |
27 |
13 |
28.9 |
0.12 |
5.5e-01 |
ADCY3 ADM AFAP1-AS1 C16orf93 C6orf106 CCDC171 CENPW GBA IQCH JUND KCNG3 KLF16 KLHL24 LINC00674 LMOD1 NEGR1 PABPC4 RARB RP1-18D14.7 SBF2 SSH2 SSR3 SYNM TBX6 THAP3 UBE2Q2P1 ZNF76 |
Trunk fat-free mass |
2.00 |
59 |
48 |
106.7 |
0.34 |
1.9e-03 |
ACSS2 ACTR1A ADM AMPD3 ATP13A2 BTBD8 C10orf11 C1orf54 C20orf24 C6orf106 CCDC66 CENPW CTC-228N24.3 DEF6 EIF6 FOXO3 GBA GIPC2 GMPPB GNA12 HHIP-AS1 ITCH LMOD1 LOXL1-AS1 MAP1LC3A MKL1 MSL1 NUCKS1 OR2AE1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PPA2 PROCR PTCH1 RALY RBBP8 RP11-435O5.5 RPL10A RPS6KL1 SBF2 SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SNX11 SNX33 SUOX TBX6 TCP11 TGFB2 TRIM4 UQCRQ ZMAT5 ZNF76 |
Hip circumference |
1.31 |
39 |
28 |
62.2 |
0.37 |
1.5e-02 |
AC103965.1 ACTR1A ADCY3 ARHGEF26 C16orf93 C6orf106 CCDC171 FOXO3 GIPC2 GMPPB GNA12 GOLGA6L4 HHIP-AS1 ITCH KB-1107E3.1 KLF16 KLHL24 LINC00674 LMOD1 MAP1LC3A NEGR1 OTUD4 PABPC4 PEF1 PTCH1 RALY RP11-182J1.14 RP11-182J1.16 RP11-435O5.5 RP1-18D14.7 RP11-95P2.1 RPL10A SMPD2 SNX11 TBX6 TRMT61B TSPAN4 UBE2Q2P1 ZSCAN2 |
Alcohol intake versus 10 years previously |
1.04 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
FUT2 NEGR1 PABPC4 |
Father's age at death |
1.07 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CHRNA5 |
Worrier / anxious feelings |
1.18 |
5 |
4 |
8.9 |
0.05 |
9.2e-01 |
ACTR1A PPP1R3B PTCH1 RPS6KL1 SERPING1 |
Frequency of tiredness / lethargy in last 2 weeks |
1.05 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
GMPPB SERPING1 |
Hair/balding pattern: Pattern 3 |
1.18 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CENPW MAP1LC3A |
Forced expiratory volume in 1-second (FEV1) |
3.38 |
73 |
49 |
108.9 |
0.75 |
2.7e-20 |
AC103965.1 ADAM19 ADAMTS5 ADCY3 AFAP1 AFAP1L1 ARHGEF17 ASCC2 ATP13A2 BCAR1 C10orf11 C1GALT1 C20orf112 CAMK1D CAMK2G CCDC171 CDC123 CENPW CHRNA5 CTD-2524L6.3 DEF6 DENND2D EFEMP1 EML3 FAM149B1 FAM168A FBXO38 GIPC2 GM2A GMPPB GOLGA6L4 HHIP-AS1 IGF2BP2 INTS12 KPNA3 LLGL2 LONRF2 LOXL1-AS1 LRRC37B MICAL3 NIPAL4 NRBF2 NUDT5 OTUD4 PCGF2 PLEKHM1P PPA2 PTCH1 RELT RP11-182J1.14 RP11-182J1.16 RP11-382A20.2 RP11-425D10.10 RP11-435O5.5 RP11-680F20.12 RP11-800A3.7 RPL10A RSL24D1P6 SEC24C SLMAP SMPD2 SOGA2 SPINK9 SUOX SYNM TCP11 TGFB2 THSD4 TTC18 UBE2Q2P1 ZNF438 ZNF76 ZSCAN2 |
Pulse rate |
1.22 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
GJA1 GNL3 PPP1R3E |
Qualifications: A levels/AS levels or equivalent |
0.99 |
5 |
2 |
4.4 |
-0.14 |
7.9e-01 |
ACTR1A GMPPB NEGR1 PPA2 SUOX |
Mouth/teeth dental problems: Dentures |
1.12 |
4 |
0 |
0.0 |
0.38 |
6.2e-01 |
CHRNA5 EIF2AK4 FUT2 HERC1 |
Asthma |
3.21 |
24 |
20 |
44.4 |
-0.71 |
4.1e-06 |
ADAM19 BACH2 C16orf93 DEF6 DMWD EEFSEC GSDMB IKZF3 IL1RL1 IL7R IQCH LRP1 LTBP3 MSL1 ORMDL3 PDLIM4 SLC22A5 SMAD3 SRGAP2 SUOX THRA UQCRQ ZNF652 ZNF76 |
Medication: Ibuprofen (e.g. Nurofen) |
1.15 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
LRP1 |
Medication: Cholesterol lowering |
1.38 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
CELSR2 FUT2 IGF2BP2 |
Prospective memory result |
1.16 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PEF1 |
Lung cancer (father) |
1.05 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CHRNA5 |
Forced expiratory volume in 1-second (FEV1), Best measure |
3.46 |
70 |
51 |
113.3 |
0.78 |
5.8e-22 |
AC103965.1 ADAM19 ADCY3 AFAP1 AFAP1L1 ARHGEF17 ASCC2 ATP13A2 BCAR1 C10orf11 C1GALT1 C20orf112 CAMK1D CAMK2G CDC123 CENPW CEPT1 CHRNA5 CTD-2524L6.3 DEF6 DENND2D DNALI1 EFEMP1 EIF6 EML3 FAM168A FBXO38 FRK GIPC2 GM2A GMPPB GOLGA6L4 HHIP-AS1 INTS12 KPNA3 LLGL2 LONRF2 LOXL1-AS1 LRRC37B MICAL3 MST1L NIPAL4 NRBF2 NUDT5 OTUD4 PAIP1 PCGF2 PDLIM4 PLEKHM1P PPA2 RELT RP11-182J1.14 RP11-182J1.16 RP11-382A20.2 RPL10A RSL24D1P6 SEC24C SLMAP SMPD2 SOGA2 SPINK9 SUOX SYNM TCP11 TGFB2 THSD4 UBE2Q2P1 ZNF438 ZNF76 ZSCAN2 |
Impedance of arm (left) |
1.60 |
59 |
40 |
88.9 |
-0.20 |
1.1e-01 |
AC103965.1 ACTR1A ADM AMPD3 ATP13A2 C10orf11 CENPW CROCC EEFSEC EFEMP1 EML3 EP300 EVI5 FOXO3 GAB2 GBA GMPPB GNA12 GNL3 GOLGA6L4 GTF2IRD2 HOXC8 ITCH JUND LMOD1 LOC400043 LOXL1-AS1 LSM3 MFAP2 MKL1 MST1L MTMR11 NEGR1 NFE2L1 NRBF2 OR2AE1 PEF1 PPP1R3B PRR15L PSTPIP1 RALY RIF1 RP11-108M9.4 RP11-108M9.5 RP11-182J1.14 RP11-182J1.16 RP11-797A18.4 RP3-395M20.9 SBF2 SCAPER SCARF2 SMG6 SUOX TBX6 TRIM4 TSPAN3 TSPAN4 UBE2Q2P1 ZNF652 |
Arm fat mass (right) |
1.17 |
25 |
19 |
42.2 |
0.38 |
5.4e-02 |
ADCY3 ARHGEF26 C16orf93 C6orf106 CCDC171 FOXO3 GMPPB IQCH ITCH JUND KLF16 KLHL24 LINC00674 LMOD1 NEGR1 OTUD4 PABPC4 RALY RP1-18D14.7 RP3-395M20.9 RPL10A SUOX TBX6 TSPAN4 UBE2Q2P1 |
Trunk predicted mass |
1.99 |
58 |
48 |
106.7 |
0.34 |
2.1e-03 |
ACSS2 ACTR1A ADM AMPD3 ATP13A2 BTBD8 C10orf11 C1orf54 C20orf24 C6orf106 CCDC66 CENPW CTC-228N24.3 DEF6 EIF6 FOXO3 GBA GIPC2 GMPPB GNA12 HHIP-AS1 ITCH LMOD1 LOXL1-AS1 MAP1LC3A MKL1 MSL1 NUCKS1 OR2AE1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PPA2 PROCR PTCH1 RALY RBBP8 RP11-435O5.5 RPL10A RPS6KL1 SBF2 SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SNX11 SNX33 SUOX TBX6 TCP11 TGFB2 TRIM4 ZMAT5 ZNF76 |
Standing height |
2.40 |
113 |
98 |
217.8 |
0.06 |
4.8e-01 |
AC103965.1 ACSS2 ADCY3 ADM AFAP1 AFAP1-AS1 ALKBH5 ASB13 ATP13A2 BTBD8 C11orf46 C20orf24 C6orf106 C9orf156 CCDC144B CCDC66 CENPW CFDP1 COG6 CRIM1 CROCC CTCF DEF6 DEPDC6 DMWD DRAM1 EFEMP1 EIF6 ERC1 EVI5 FAM69A FOXO3 FRK FUT2 FZR1 GNA12 GNL3 GNPTAB GOLGA6L4 GRK5 HHIP-AS1 HMGN1 HOXB-AS1 ISCA1 ITCH KIAA0753 LLGL2 LOX LOXL1-AS1 LRP1 LRRC37B LSM3 MAP1LC3A MFAP2 MRC2 MRPS6 MSL1 MST1L MTMR11 MUTYH NFE2L1 NUCKS1 OTUD4 PABPC4 PADI2 PDLIM4 PEAK1 PGD PIP4K2B PLEKHA1 PLEKHM1P PPA2 PROCR PRR15L PSTPIP1 PTCH1 RALY RBBP8 RP11-108M9.4 RP11-108M9.5 RP11-165J3.6 RP11-182J1.14 RP11-182J1.16 RP11-382A20.2 RP11-425D10.10 RP11-435O5.5 RP11-797A18.4 RP11-95P2.1 RPL10A RPS6KL1 RRP15 SBF2 SCAPER SH3D21 SLC22A5 SLC2A9 SMPD2 SNX11 SSH2 ST3GAL4 STRA13 TBX6 TCP11 TGFB2 TMEM170A TSPAN3 UBE2Q2 UBE2Q2P1 UQCRQ ZNF438 ZNF652 ZNF76 ZSCAN2 |
Exposure to tobacco smoke at home |
0.95 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
GMPPB |
Tense / 'highly strung' |
1.06 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
NUCKS1 PTCH1 |
Seen doctor (GP) for nerves, anxiety, tension or depression |
1.10 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
NEGR1 RPS6KL1 |
Hair/balding pattern: Pattern 4 |
1.10 |
8 |
3 |
6.7 |
0.03 |
9.4e-01 |
C10orf11 CENPW CTCF HSPA4 ITCH MAP1LC3A RIOK1 VGLL4 |
Birth weight of first child |
1.78 |
7 |
3 |
6.7 |
0.57 |
4.4e-02 |
ARMC2 CRIM1 OTUD4 PPA2 SUOX TMEM170A ZNF76 |
Peak expiratory flow (PEF) |
3.05 |
40 |
19 |
42.2 |
0.92 |
2.1e-26 |
AC010883.5 ACSS2 ADAM19 ADAMTS5 ARHGEF17 BCAR1 BMP4 C10orf11 C1GALT1 CAMK1D CDC123 DEF6 EIF6 FAM168A FBXO38 FUT2 FZR1 GIPC2 HHIP-AS1 HOXB2 HOXB-AS1 IGF2BP2 MAP1LC3A NUCKS1 NUDT5 OTUD4 PPA2 RARB RELT RP11-800A3.7 SBSPON SMPD2 SPINK9 SSH2 TCP11 TCTN2 TGFB2 THSD4 TMEM170A ZNF76 |
Pulse wave reflection index |
1.17 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PPP1R3E |
Blood clot in the leg (DVT) |
1.17 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
EIF6 PROCR |
Medication: Paracetamol |
1.18 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
GMPPB LRP1 |
Headache pain in last month |
1.45 |
6 |
3 |
6.7 |
0.11 |
8.3e-01 |
BCAR1 LRP1 PPP1R3B SLC24A3 SUOX TMEM170A |
Medication for cholesterol, blood pressure or diabetes |
1.40 |
6 |
3 |
6.7 |
0.71 |
1.2e-01 |
ARHGAP42 ATP2B1 CAMK1D CELSR2 FUT2 ZNF652 |
Glaucoma (self-reported) |
1.11 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
AFAP1 AFAP1-AS1 |
Hypothyroidism/myxoedema (self-reported) |
1.23 |
8 |
6 |
13.3 |
0.02 |
9.7e-01 |
ARMC2 BACH2 C9orf156 CTCF NCBP1 PLEKHA1 SUOX ZNF76 |
Medication: Ventolin 100micrograms inhaler |
2.03 |
7 |
5 |
11.1 |
-0.98 |
2.6e-06 |
FOXO1 GSDMB IKZF3 IL1RL1 ORMDL3 SMAD3 ZNF652 |
Birth weight |
1.68 |
12 |
5 |
11.1 |
0.25 |
3.8e-01 |
ARMC2 CENPW DTWD1 FCGR2B GNA12 NUCKS1 PPA2 PTCH1 RP11-425D10.10 RP11-435O5.5 SHB ZNF76 |
Chronic bronchitis/emphysema (mother) |
1.28 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CHRNA5 HHIP-AS1 RARB |
High blood pressure (siblings) |
1.21 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
NRBF2 |
Forced vital capacity (FVC), Best measure |
2.33 |
59 |
37 |
82.2 |
-0.08 |
4.9e-01 |
AC103965.1 ADCY3 ATP13A2 BMF BTBD8 C10orf11 C5orf63 CCDC171 CDC123 CDK5RAP3 CENPW CHRNA5 CRIM1 CROCC DEF6 DRAM1 EFEMP1 EML3 ERC1 GNA12 GNPTAB HHIP-AS1 INTS12 IQCH LONRF2 LOXL1-AS1 MFAP2 MSL1 MST1L NFE2L1 NUDT5 OTUD4 PADI2 PCSK7 PIP4K2B PLEKHM1P PPA2 PSTPIP1 PTCH1 RP11-108M9.4 RP11-108M9.5 RP11-182J1.14 RP11-182J1.16 RP11-382A20.2 RP11-435O5.5 RPL10A RRP15 SCAPER SEC24C SH3D21 SHKBP1 SMPD2 SMURF2 SSH2 TCP11 TGFB2 UBE2Q2P1 ZNF438 ZNF76 |
Body fat percentage |
1.27 |
34 |
20 |
44.4 |
0.41 |
1.2e-02 |
AC103965.1 ADCY3 ADM C16orf93 C6orf106 CCDC171 CENPW CTC-228N24.3 FOXO3 GBA GOLGA6L4 HOXC8 IQCH JUND KCNG3 KLF16 KLHL24 LINC00674 LMOD1 NEGR1 NTM RARB RP11-165J3.6 RP11-182J1.14 RP11-182J1.16 RP1-18D14.7 RP11-95P2.1 RPS6KL1 SBF2 SSH2 SYNM THAP3 UBE2Q2P1 ZSCAN2 |
Leg fat percentage (right) |
1.39 |
33 |
17 |
37.8 |
0.54 |
1.2e-03 |
ADCY3 ADM C6orf106 CCDC171 CDK5RAP3 CENPW CTC-228N24.3 EIF6 GMPPB GOLGA6L4 IQCH JUND LINC00674 LMOD1 LRP1 MLLT10 MUTYH NBAS NEGR1 NFE2L1 PLEKHM1P PRIM2 RP11-165J3.6 RP11-182J1.14 RP11-182J1.16 RP11-95P2.1 RP3-395M20.9 RPS6KL1 SBF2 SSH2 SYNM THAP3 UBE2Q2P1 |
Arm fat-free mass (right) |
1.87 |
56 |
44 |
97.8 |
0.42 |
1.7e-04 |
ACSS2 ACTR1A ADM ARHGEF26 BTBD8 C10orf11 C16orf93 C20orf24 C6orf106 CCDC66 CENPW DEF6 EIF6 FOXO3 GBA GIPC2 GMPPB GNA12 HHIP-AS1 ITCH LMOD1 LOXL1-AS1 MAP1LC3A MET MKL1 NEGR1 NUCKS1 OR2AE1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PPA2 PROCR PTCH1 RALY RBBP8 RP11-435O5.5 RP3-395M20.9 RPL10A SBF2 SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SUOX TBX6 TCP11 TGFB2 TRIM4 TSPAN4 ZMAT5 ZNF76 |
Comparative body size at age 10 |
1.49 |
12 |
9 |
20.0 |
0.33 |
2.8e-01 |
ADCY3 ATP6V0D1 C16orf93 EP300 FGFR1 FUT2 GOLGA6L4 NEGR1 NUCKS1 PAN3-AS1 VGLL4 ZNF652 |
Worry too long after embarrassment |
1.14 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
PPA2 SERPING1 |
Wheeze or whistling in the chest in last year |
1.89 |
10 |
6 |
13.3 |
-0.78 |
6.4e-04 |
ADAM19 BACH2 GMPPB GSDMB IKZF3 IL1RL1 MSL1 ORMDL3 SMAD3 THRA |
Age at first live birth |
1.03 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
GMPPB |
Qualifications: College or University degree |
1.22 |
17 |
12 |
26.7 |
0.28 |
1.9e-01 |
ACTR1A CCDC144B EIF6 EML3 FOXO3 GMPPB HAUS4 JUND LMOD1 MAP1LC3A MET NEGR1 NIPSNAP1 PPA2 PROCR RP11-298I3.1 SUOX |
Medication for pain relief, constipation, heartburn |
1.26 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
LRP1 RPS6KL1 |
Medication: Blood pressure |
1.40 |
4 |
3 |
6.7 |
-0.99 |
1.3e-02 |
ARHGAP42 ATP2B1 CEP41 ZNF652 |
Angina (self-reported) |
1.28 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CELSR2 ZNF652 |
Migraine (self-reported) |
1.16 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
LRP1 SLC24A3 |
Medication: Ibuprofen |
1.14 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
LRP1 |
Medication: Seretide 50 evohaler |
1.57 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
IL1RL1 ZNF652 |
Mean time to correctly identify matches |
1.08 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
FOXO3 NUCKS1 |
Whole body fat mass |
1.26 |
34 |
24 |
53.3 |
0.41 |
1.2e-02 |
AC103965.1 ADCY3 ARHGEF26 C16orf93 C6orf106 CCDC171 FOXO3 GMPPB GNA12 GOLGA6L4 IQCH ITCH JUND KB-1107E3.1 KLF16 KLHL24 LINC00674 LMOD1 NEGR1 OTUD4 PABPC4 RP11-182J1.14 RP11-182J1.16 RP1-18D14.7 RP11-95P2.1 RP3-395M20.9 RPL10A SNX11 SUOX SYNM TBX6 THAP3 UBE2Q2P1 ZSCAN2 |
Leg fat mass (right) |
1.26 |
37 |
22 |
48.9 |
0.52 |
7.2e-04 |
ACTR1A ADCY3 ARHGEF26 C16orf93 C6orf106 CCDC171 FOXO3 GIPC2 GMPPB GOLGA6L4 IQCH ITCH JUND KB-1107E3.1 KLF16 KLHL24 LINC00674 LMOD1 MLLT10 NBAS NEGR1 OTUD4 PABPC4 PEF1 RALY RP11-182J1.14 RP11-182J1.16 RP1-18D14.7 RP11-95P2.1 RP3-395M20.9 RPL10A SSH2 SUOX TBX6 THAP3 UBE2Q2P1 ZSCAN2 |
Arm predicted mass (right) |
1.86 |
58 |
44 |
97.8 |
0.40 |
2.6e-04 |
ACSS2 ACTR1A ADM ARHGEF26 ARVCF BTBD8 C10orf11 C16orf93 C20orf24 C6orf106 CCDC66 CENPW DEF6 EIF6 FOXO3 GBA GIPC2 GMPPB GNA12 HHIP-AS1 ITCH LMOD1 LOXL1-AS1 MAP1LC3A MET MKL1 NEGR1 NUCKS1 OR2AE1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PPA2 PROCR PTCH1 RALY RBBP8 RP11-182J1.16 RP11-435O5.5 RP3-395M20.9 RPL10A SBF2 SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SUOX TBX6 TCP11 TGFB2 TRIM4 TSPAN4 ZMAT5 ZNF76 |
Pulse rate, automated reading |
1.42 |
24 |
12 |
26.7 |
-0.15 |
4.7e-01 |
ALKBH5 AP4M1 C6orf106 EIF2AK4 EML3 GAB2 GJA1 GNL3 HERC1 HMGN1 LOC100133893 MET MUTYH NEGR1 PABPC4 PCGF2 PPP1R3E RP11-351A11.1 RP11-382A20.2 RP11-95P2.1 SERPING1 SERTAD2 SUOX SYS1-DBNDD2 |
Alcohol intake frequency. |
1.07 |
5 |
2 |
4.4 |
0.25 |
6.3e-01 |
CCDC144B FUT2 LRP1 PPA2 SUOX |
Comparative height size at age 10 |
2.05 |
66 |
54 |
120.0 |
0.14 |
1.7e-01 |
AC010883.5 AC103965.1 ACSS2 ADCY3 ATP13A2 C10orf11 C20orf24 C6orf106 C9orf156 CENPW CRIM1 CROCC DEF6 EFEMP1 EIF6 EVI5 FAM69A FOXO3 FUT2 GNA12 GOLGA6L4 HHIP-AS1 ITCH JUND LOXL1-AS1 MAP1LC3A MFAP2 MRPS6 MSL1 MST1L MTMR11 NUCKS1 OTUD4 PADI2 PDLIM4 PIP4K2B PLEKHA1 PLEKHM1P PPA2 PROCR PSTPIP1 PTCH1 RBBP8 RP11-108M9.4 RP11-108M9.5 RP11-165J3.6 RP11-182J1.14 RP11-182J1.16 RP11-435O5.5 RP11-797A18.4 RPL10A RPS6KL1 SH3D21 SLC22A5 SMPD2 TBX6 TCP11 TGFB2 TMEM170A TMEM41B UBE2Q2 UBE2Q2P1 UQCRQ ZNF438 ZNF76 ZSCAN2 |
Number of full sisters |
1.29 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NRBF2 |
Suffer from 'nerves' |
0.97 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
PTCH1 RPS6KL1 TBX6 |
Overall health rating |
1.15 |
4 |
3 |
6.7 |
-0.54 |
4.6e-01 |
GMPPB LINC00674 LMOD1 ZNF652 |
Chest pain or discomfort |
1.25 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
IL1RL1 |
Had major operations |
1.01 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZNF652 |
Age at last live birth |
1.02 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
GMPPB |
Medication: Aspirin |
1.17 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
CELSR2 DEPDC6 IGF2BP2 |
Knee pain experienced in last month |
1.06 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PABPC4 |
Hypertension (Self-reported) |
1.50 |
18 |
10 |
22.2 |
-0.18 |
4.4e-01 |
ARHGAP42 ATP2B1 C1GALT1 CEP41 CFDP1 FUT2 HOXC8 HSPA4 KB-1107E3.1 MET NRBF2 PDLIM4 RPAP1 SLC22A5 SUOX TPRA1 TSPAN3 ZNF652 |
Illnesses of father: Heart disease |
1.29 |
4 |
2 |
4.4 |
0.31 |
6.9e-01 |
CELSR2 RP11-378J18.8 SMAD3 SMG6 |
Illnesses of siblings: Diabetes |
1.10 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
IGF2BP2 |
Forced expiratory volume in 1-second (FEV1), predicted |
1.98 |
27 |
19 |
42.2 |
0.39 |
1.6e-02 |
AC103965.1 ADCY3 ATP13A2 C6orf106 CENPW DEF6 EIF6 GNA12 GOLGA6L4 HHIP-AS1 LOXL1-AS1 MAP1LC3A MST1L OTUD4 PDLIM4 PROCR PTCH1 RP11-182J1.14 RP11-182J1.16 RP11-435O5.5 RPL10A SLC22A5 TCP11 TGFB2 UBE2Q2P1 ZNF76 ZSCAN2 |
Whole body fat-free mass |
1.89 |
64 |
47 |
104.4 |
0.36 |
5.5e-04 |
ACSS2 ACTR1A ADM AMPD3 ARHGEF26 BTBD8 C10orf11 C16orf93 C1orf54 C20orf24 C6orf106 CCDC66 CENPW CTC-228N24.3 DEF6 EIF6 EPHA2 FOXO3 FZR1 GBA GIPC2 GMPPB GNA12 HHIP-AS1 ITCH LMOD1 LOXL1-AS1 MAP1LC3A MET MKL1 MSL1 NEGR1 NUCKS1 OR2AE1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PPA2 PROCR PTCH1 RALY RBBP8 RP11-435O5.5 RPL10A SBF2 SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SNX11 SNX33 SUOX TBX6 TCP11 TGFB2 TRIM4 TSPAN4 UQCRQ ZMAT5 ZNF76 |
Leg fat-free mass (right) |
1.71 |
56 |
43 |
95.6 |
0.33 |
3.0e-03 |
ACSS2 ACTR1A ADM ARHGEF26 BTBD8 C10orf11 C16orf93 C1orf54 C20orf24 C5orf63 C6orf106 CENPW CTC-228N24.3 DEF6 EIF6 EPHA2 FOXO3 FZR1 GMPPB GNA12 HHIP-AS1 ITCH LMOD1 MAP1LC3A MSL1 NEGR1 NUCKS1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PLEKHM1P PPA2 PROCR PTCH1 RALY RP11-435O5.5 RPL10A SBF2 SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SNX11 SNX33 SUOX TBX6 TCP11 TGFB2 TSPAN4 UQCRQ ZMAT5 ZNF76 |
Arm fat percentage (left) |
1.19 |
28 |
14 |
31.1 |
0.07 |
7.1e-01 |
ADCY3 AFAP1 AFAP1-AS1 C16orf93 C6orf106 CCDC171 CENPW GBA HOXC8 IQCH JUND KCNG3 KLF16 KLHL24 LINC00674 LMOD1 NEGR1 OXER1 PABPC4 RP1-18D14.7 SBF2 SSH2 SSR3 SYNM TBX6 THAP3 UBE2Q2P1 ZNF76 |
Average weekly red wine intake |
1.10 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SERPING1 |
Mood swings |
1.07 |
4 |
2 |
4.4 |
-0.78 |
6.9e-02 |
FBXO38 GMPPB NUCKS1 RPS6KL1 |
Long-standing illness, disability or infirmity |
1.28 |
4 |
0 |
0.0 |
-0.53 |
4.7e-01 |
CCDC171 EMB NEGR1 ZNF652 |
Diabetes diagnosed by doctor |
1.69 |
6 |
3 |
6.7 |
0.13 |
8.1e-01 |
AC010883.5 CFDP1 CLPB IGF2BP2 LOC100133893 PLA2G4B |
Qualifications: nursing, teaching |
1.15 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CFH NEGR1 PPA2 |
Eye problems/disorders: Cataract |
1.03 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SLC24A3 |
Mouth/teeth dental problems: Mouth ulcers |
1.10 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
GSDMB IKZF3 |
Medication for cholesterol |
1.40 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
FUT2 MTA3 |
Back pain experienced in last month |
1.11 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
C6orf106 |
Asthma (self-reported) |
3.24 |
24 |
19 |
42.2 |
-0.71 |
3.1e-06 |
ADAM19 BACH2 C16orf93 DDX5 DEF6 DMWD EEFSEC GSDMB IKZF3 IL1RL1 IL7R IQCH LRP1 MSL1 ORMDL3 PDLIM4 SLC22A5 SMAD3 SRGAP2 SUOX THRA UQCRQ ZNF652 ZNF76 |
Osteoarthritis (self-reported) |
1.16 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MBL1P |
Medication: Aspirin |
1.18 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
CELSR2 IGF2BP2 |
Medication: Gliclazide |
1.18 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
IGF2BP2 |
Smoking status: Current |
1.20 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ACTR1A |
Forced expiratory volume in 1-second (FEV1), predicted percentage |
2.74 |
31 |
15 |
33.3 |
0.92 |
2.5e-21 |
ADAM19 ASCC2 BCAR1 C10orf11 CAMK1D CAMK2G CDC123 CHRNA5 EML3 FBXO38 GMPPB HHIP-AS1 INTS12 KPNA3 LLGL2 MICAL3 NRBF2 OTUD4 PCGF2 PPA2 RARB RP11-382A20.2 RPL10A SEC24C SLMAP SMPD2 SOGA2 SPINK9 TCP11 TMEM170A ZNF76 |
Whole body water mass |
1.89 |
63 |
47 |
104.4 |
0.36 |
6.2e-04 |
ACSS2 ACTR1A ADM AMPD3 ARHGEF26 BTBD8 C10orf11 C16orf93 C1orf54 C20orf24 C6orf106 CCDC66 CENPW CTC-228N24.3 DEF6 EIF6 EPHA2 FOXO3 FZR1 GBA GIPC2 GMPPB GNA12 HHIP-AS1 ITCH LMOD1 LOXL1-AS1 MAP1LC3A MKL1 MSL1 NEGR1 NUCKS1 OR2AE1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PPA2 PROCR PTCH1 RALY RBBP8 RP11-435O5.5 RPL10A SBF2 SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SNX11 SNX33 SUOX TBX6 TCP11 TGFB2 TRIM4 TSPAN4 UQCRQ ZMAT5 ZNF76 |
Leg predicted mass (right) |
1.71 |
57 |
44 |
97.8 |
0.32 |
4.1e-03 |
ACSS2 ACTR1A ADM ARHGEF26 BTBD8 C10orf11 C16orf93 C1orf54 C20orf24 C5orf63 C6orf106 CENPW CTC-228N24.3 DEF6 EIF6 EPHA2 FOXO3 FZR1 GMPPB GNA12 HHIP-AS1 ITCH LMOD1 LOXL1-AS1 MAP1LC3A MSL1 NEGR1 NUCKS1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PLEKHM1P PPA2 PROCR PTCH1 RALY RP11-435O5.5 RPL10A SBF2 SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SNX11 SNX33 SUOX TBX6 TCP11 TGFB2 TSPAN4 UQCRQ ZMAT5 ZNF76 |
Arm fat mass (left) |
1.17 |
25 |
19 |
42.2 |
0.32 |
1.1e-01 |
ADCY3 ARHGEF26 C16orf93 C6orf106 CCDC171 FOXO3 GMPPB GNA12 IQCH ITCH JUND KLF16 KLHL24 LINC00674 LMOD1 NEGR1 OTUD4 PABPC4 RALY RP1-18D14.7 RP3-395M20.9 RPL10A SUOX TBX6 TSPAN4 |
Number of self-reported non-cancer illnesses |
1.38 |
5 |
2 |
4.4 |
-0.99 |
1.3e-03 |
GSDMB IL1RL1 IQCH NEGR1 ZNF652 |
Miserableness |
1.02 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
GMPPB LOXL1-AS1 PPP1R3B |
Guilty feelings |
1.19 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
PTCH1 RPS6KL1 |
Eye problems/disorders: Glaucoma |
1.13 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
AFAP1 AFAP1-AS1 |
Medication: Blood pressure |
1.31 |
5 |
2 |
4.4 |
-0.44 |
3.8e-01 |
ARHGAP42 C1GALT1 HOXC8 NRBF2 SLC22A5 |
High cholesterol (Self-reported) |
1.28 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
CELSR2 FUT2 |
Medication: Bendroflumethiazide |
1.22 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ATP2B1 |
Medication: Paracetamol |
1.16 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
GMPPB LRP1 |
Medication: Lisinopril |
1.21 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
NRBF2 XPA |
Medication: Atorvastatin |
1.25 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CELSR2 |
Ever smoked |
1.20 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ACTR1A ZFHX3 |
Basal metabolic rate |
1.79 |
66 |
46 |
102.2 |
0.39 |
1.9e-04 |
ACSS2 ACTR1A ADM ARHGEF26 BTBD8 C10orf11 C16orf93 C1orf54 C20orf24 C6orf106 CCDC66 CENPW CTC-228N24.3 DEF6 EIF6 EPHA2 FOXO3 FZR1 GIPC2 GMPPB GNA12 HHIP-AS1 ISCA1 ITCH LINC00674 LMOD1 LOXL1-AS1 MAP1LC3A MET MKL1 NEGR1 NUCKS1 OR2AE1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PPA2 PROCR PTCH1 RALY RBBP8 RP11-182J1.16 RP11-435O5.5 RP11-95P2.1 RPL10A SBF2 SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SNX11 SNX33 SUOX TBX6 TCP11 TGFB2 TRIM4 TRMT61B TSPAN4 UQCRQ ZMAT5 ZNF76 |
Leg fat percentage (left) |
1.37 |
34 |
16 |
35.6 |
0.54 |
7.2e-04 |
ADCY3 ADM C6orf106 CCDC171 CDK5RAP3 CENPW CTC-228N24.3 EIF6 FOXO3 GMPPB GOLGA6L4 GRK5 IQCH JUND LINC00674 LMOD1 LRP1 MLLT10 MUTYH NBAS NEGR1 NFE2L1 PTCH1 RP11-165J3.6 RP11-182J1.14 RP11-435O5.5 RP11-95P2.1 RP3-395M20.9 RPS6KL1 SBF2 SSH2 SYNM THAP3 UBE2Q2P1 |
Arm fat-free mass (left) |
1.79 |
59 |
45 |
100.0 |
0.41 |
2.0e-04 |
ACSS2 ACTR1A ADM ARHGEF26 BTBD8 C10orf11 C16orf93 C20orf24 C6orf106 CCDC66 CENPW DEF6 EIF6 FOXO3 GBA GIPC2 GMPPB GNA12 HHIP-AS1 ITCH LMOD1 LOXL1-AS1 MAP1LC3A MET MKL1 NEGR1 NUCKS1 OR2AE1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PPA2 PROCR PTCH1 RALY RBBP8 RP11-435O5.5 RP3-395M20.9 RPL10A SBF2 SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SNX11 SNX33 SUOX TBX6 TCP11 TGFB2 TRIM4 TRMT61B TSPAN4 ZMAT5 ZNF76 |
Number of operations (self-reported) |
1.29 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
PPA2 |
Average weekly beer plus cider intake |
1.22 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PCM1 |
Irritability |
1.14 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
AC010883.5 FCHO2 |
Fractured/broken bones in last 5 years |
1.07 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
FAM3C |
Diastolic blood pressure, automated reading |
1.52 |
27 |
15 |
33.3 |
0.17 |
3.6e-01 |
ADM ARHGAP42 ATP2A3 ATP2B1 C1GALT1 DEF6 DPY19L2P4 HAUS4 KLF16 LMOD1 LSMD1 MAPKBP1 MICAL3 NRBF2 PLA2G4B PPP1R3B RP11-351A11.1 RP11-800A3.7 RPAP1 SBF2 SLC24A3 SLMAP TCP11 THSD4 TPRA1 ULK4 ZNF652 |
Ever depressed for a whole week |
1.00 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
GMPPB |
Myopia |
1.09 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
BMP4 LRP1 |
Vascular/heart problems diagnosed by doctor |
1.47 |
16 |
10 |
22.2 |
0.42 |
8.3e-02 |
ARHGAP42 ATP2B1 C1GALT1 CEP41 CFDP1 FUT2 HOXC8 HSPA4 KB-1107E3.1 MET NRBF2 PDLIM4 SLC22A5 SMG6 TSPY26P ZNF652 |
Cholesterol lowering medication |
1.24 |
4 |
2 |
4.4 |
-0.09 |
9.1e-01 |
CELSR2 EPHA2 FUT2 SSH2 |
Pain experienced in last month |
1.17 |
7 |
3 |
6.7 |
0.57 |
1.8e-01 |
CENPW GMPPB HNRNPUL1 LRP1 PABPC4 RAB4B SUOX |
Basal cell carcinoma (self-reported) |
1.16 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ITGA2 |
Heart attack/myocardial infarction (self-reported) |
1.16 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CELSR2 RP11-378J18.8 ZNF652 |
Deep venous thrombosis (DVT) (self-reported) |
1.21 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
EIF6 PROCR |
Heart disease (siblings) |
1.31 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP11-378J18.8 |
Pack years of smoking |
1.52 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
CHRNA5 RAB4B |
Impedance of whole body |
1.63 |
69 |
52 |
115.6 |
-0.12 |
3.2e-01 |
AC010883.5 AC103965.1 ACTR1A ADCY3 ADM AMPD3 ARVCF ATP13A2 BCAR1 BTBD8 C10orf11 C6orf106 CENPW CEP41 CROCC CTC-228N24.3 EFEMP1 EP300 EVI5 FOXO3 GAB2 GBA GMPPB GNL3 GOLGA6L4 GTF2IRD2 HELLS HOXC8 ITCH JUND KLF16 LMOD1 LOC400043 LSM3 MFAP2 MKL1 MST1L MTMR11 NEGR1 NFE2L1 NIPSNAP1 NUCKS1 OR2AE1 OTUD4 PABPC4 PEAK1 PEF1 PSTPIP1 PTCH1 RALY RIF1 RP11-108M9.5 RP11-182J1.14 RP11-182J1.16 RP11-797A18.4 RP3-395M20.9 SBF2 SCAPER SCARF2 SMG6 SNX33 SUOX TBX6 TRIM4 TSPAN3 TSPAN4 UBE2Q2P1 ZNF652 ZSCAN2 |
Leg fat mass (left) |
1.25 |
35 |
21 |
46.7 |
0.47 |
3.8e-03 |
ACTR1A ADCY3 C16orf93 C6orf106 CCDC171 FOXO3 GIPC2 GMPPB GOLGA6L4 IQCH ITCH JUND KLF16 KLHL24 LINC00674 LMOD1 MLLT10 NBAS NEGR1 OTUD4 PABPC4 PEF1 RALY RP11-182J1.14 RP11-182J1.16 RP1-18D14.7 RP11-95P2.1 RP3-395M20.9 RPL10A SUOX TBX6 THAP3 UBE2Q2P1 ZMAT5 ZSCAN2 |
Arm predicted mass (left) |
1.81 |
59 |
43 |
95.6 |
0.41 |
1.7e-04 |
ACSS2 ACTR1A ADM ARHGEF26 BTBD8 C10orf11 C16orf93 C20orf24 C6orf106 CCDC66 CENPW DEF6 EIF6 FOXO3 GBA GIPC2 GMPPB GNA12 HHIP-AS1 ITCH LMOD1 LOXL1-AS1 MAP1LC3A MET MKL1 NEGR1 NUCKS1 OR2AE1 OTUD4 PABPC4 PDLIM4 PEF1 PIP4K2B PLEKHA1 PPA2 PROCR PTCH1 RALY RBBP8 RP11-435O5.5 RP3-395M20.9 RPL10A SBF2 SCARF2 SH3D21 SLC22A5 SMG6 SMPD2 SNX11 SNX33 SUOX TBX6 TCP11 TGFB2 TRIM4 TRMT61B TSPAN4 ZMAT5 ZNF76 |